{
    "hands_on_practices": [
        {
            "introduction": "The fundamental driver of stone formation is a state of supersaturation, where the concentration of stone-forming minerals in urine exceeds their solubility limit. To assess this risk quantitatively, we must move beyond simple concentration to the concept of chemical activity. This practice provides a foundational exercise in calculating the Ion Activity Product (IAP) and the resulting supersaturation ratio ($S$), which together offer a precise measure of the thermodynamic driving force for crystallization in a patient's urine .",
            "id": "4464536",
            "problem": "A patient with recurrent urolithiasis presents with imaging signs of early hydronephrosis attributed to suspected calcium oxalate crystallization in the renal pelvis. Consider the dissolution equilibrium of calcium oxalate monohydrate, written as $\\,\\text{CaC}_{2}\\text{O}_{4}(s) \\rightleftharpoons \\text{Ca}^{2+} + \\text{C}_{2}\\text{O}_{4}^{2-}\\,$, and use the fundamental definition that the equilibrium solubility product constant $\\,K_{sp}\\,$ relates to ionic activities. The urine laboratory report provides concentrations $[\\text{Ca}^{2+}] = 3\\,\\text{mmol L}^{-1}$ and $[\\text{C}_{2}\\text{O}_{4}^{2-}] = 0.3\\,\\text{mmol L}^{-1}$, with activity coefficients $\\gamma_{\\text{Ca}} = 0.35$ and $\\gamma_{\\text{Ox}} = 0.35$ under the prevailing ionic strength. The tabulated solubility product constant for calcium oxalate monohydrate is $K_{sp} = 2.3 \\times 10^{-9}\\,(\\text{mol L}^{-1})^{2}$.\n\nUsing appropriate conversions from millimolar to molar and the fundamental definitions of ionic activity and the law of mass action, compute the Ion Activity Product (IAP) for calcium oxalate and the saturation ratio $S$ relative to $K_{sp}$. Express the IAP in $(\\text{mol L}^{-1})^{2}$ and express $S$ as a unitless decimal. Round both quantities to three significant figures.",
            "solution": "The problem will be validated by first extracting all given information and then assessing its scientific and logical integrity.\n\n### Step 1: Extract Givens\n- **Chemical Equilibrium**: The dissolution of calcium oxalate monohydrate is given as $\\,\\text{CaC}_{2}\\text{O}_{4}(s) \\rightleftharpoons \\text{Ca}^{2+} + \\text{C}_{2}\\text{O}_{4}^{2-}$.\n- **Calcium Ion Concentration**: $[\\text{Ca}^{2+}] = 3\\,\\text{mmol L}^{-1}$.\n- **Oxalate Ion Concentration**: $[\\text{C}_{2}\\text{O}_{4}^{2-}] = 0.3\\,\\text{mmol L}^{-1}$.\n- **Calcium Ion Activity Coefficient**: $\\gamma_{\\text{Ca}} = 0.35$.\n- **Oxalate Ion Activity Coefficient**: $\\gamma_{\\text{Ox}} = 0.35$.\n- **Solubility Product Constant**: $K_{sp} = 2.3 \\times 10^{-9}\\,(\\text{mol L}^{-1})^{2}$.\n- **Required Calculations**: Compute the Ion Activity Product (IAP) and the saturation ratio ($S$).\n- **Output Requirements**: Express IAP in $(\\text{mol L}^{-1})^{2}$ and $S$ as a unitless decimal, both rounded to three significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed against the required criteria:\n- **Scientifically Grounded**: The problem is based on the fundamental principles of chemical equilibrium, specifically the solubility of sparingly soluble salts. The concepts of solubility product ($K_{sp}$), activity, activity coefficients, and the Ion Activity Product (IAP) are central to physical chemistry and its application in fields like medicine and geology. The context of urolithiasis (kidney stone formation) and the involvement of calcium oxalate are factually correct and clinically relevant. The values provided for concentrations, activity coefficients, and $K_{sp}$ are physically and physiologically plausible.\n- **Well-Posed and Complete**: The problem is well-posed, as it provides all necessary data and definitions to calculate the requested quantities. A unique solution can be determined through a standard, sequential calculation.\n- **Objective and Unambiguous**: The problem is stated in precise, objective language. All terms like \"activity coefficient\", \"solubility product constant\", and \"Ion Activity Product\" have rigorous scientific definitions, leaving no room for subjective interpretation.\n\n### Step 3: Verdict and Action\nThe problem statement is scientifically sound, well-posed, and complete. It is a valid problem that can be solved using standard principles of chemical thermodynamics. The solution process may proceed.\n\n### Solution Derivation\nThe state of a solution with respect to a sparingly soluble salt is determined by comparing the Ion Activity Product (IAP) with the thermodynamic solubility product constant ($K_{sp}$).\n\nThe dissolution equilibrium is:\n$$ \\text{CaC}_{2}\\text{O}_{4}(s) \\rightleftharpoons \\text{Ca}^{2+}(aq) + \\text{C}_{2}\\text{O}_{4}^{2-}(aq) $$\nThe thermodynamic equilibrium constant, $K_{sp}$, is defined in terms of the activities ($a$) of the product ions:\n$$ K_{sp} = a_{\\text{Ca}^{2+}} \\cdot a_{\\text{C}_{2}\\text{O}_{4}^{2-}} $$\nThe activity of the pure solid, $\\text{CaC}_{2}\\text{O}_{4}(s)$, is defined as $1$.\n\nThe activity, $a_i$, of an ion $i$ is related to its molar concentration, $[i]$, and its activity coefficient, $\\gamma_i$, by the equation:\n$$ a_i = \\gamma_i [i] $$\n\nThe Ion Activity Product (IAP) has the same form as the $K_{sp}$ expression but uses the actual ion activities present in the solution at a given moment, which may not be at equilibrium.\n$$ \\text{IAP} = a_{\\text{Ca}^{2+}} \\cdot a_{\\text{C}_{2}\\text{O}_{4}^{2-}} = (\\gamma_{\\text{Ca}} [\\text{Ca}^{2+}]) \\cdot (\\gamma_{\\text{Ox}} [\\text{C}_{2}\\text{O}_{4}^{2-}]) $$\n\nFirst, the given ion concentrations must be converted from millimoles per liter ($\\text{mmol L}^{-1}$) to moles per liter ($\\text{mol L}^{-1}$) to be dimensionally consistent with the units of $K_{sp}$.\nGiven $[\\text{Ca}^{2+}] = 3\\,\\text{mmol L}^{-1}$ and $[\\text{C}_{2}\\text{O}_{4}^{2-}] = 0.3\\,\\text{mmol L}^{-1}$:\n$$ [\\text{Ca}^{2+}] = 3 \\times 10^{-3}\\,\\text{mol L}^{-1} $$\n$$ [\\text{C}_{2}\\text{O}_{4}^{2-}] = 0.3 \\times 10^{-3}\\,\\text{mol L}^{-1} = 3 \\times 10^{-4}\\,\\text{mol L}^{-1} $$\n\nNow, we can calculate the IAP using the given activity coefficients, $\\gamma_{\\text{Ca}} = 0.35$ and $\\gamma_{\\text{Ox}} = 0.35$:\n$$ \\text{IAP} = (0.35 \\times (3 \\times 10^{-3}\\,\\text{mol L}^{-1})) \\times (0.35 \\times (3 \\times 10^{-4}\\,\\text{mol L}^{-1})) $$\n$$ \\text{IAP} = (0.35)^{2} \\times (3 \\times 10^{-3}) \\times (3 \\times 10^{-4})\\,(\\text{mol L}^{-1})^{2} $$\n$$ \\text{IAP} = 0.1225 \\times 9 \\times 10^{-7}\\,(\\text{mol L}^{-1})^{2} $$\n$$ \\text{IAP} = 1.1025 \\times 10^{-7}\\,(\\text{mol L}^{-1})^{2} $$\nAs per the problem's instruction, this value must be rounded to three significant figures:\n$$ \\text{IAP} \\approx 1.10 \\times 10^{-7}\\,(\\text{mol L}^{-1})^{2} $$\n\nNext, we compute the saturation ratio, $S$, which is the ratio of the IAP to the $K_{sp}$. This dimensionless quantity indicates the degree of supersaturation.\n$$ S = \\frac{\\text{IAP}}{K_{sp}} $$\nUsing the unrounded IAP for intermediate calculation precision and the given $K_{sp} = 2.3 \\times 10^{-9}\\,(\\text{mol L}^{-1})^{2}$:\n$$ S = \\frac{1.1025 \\times 10^{-7}}{2.3 \\times 10^{-9}} $$\n$$ S = \\frac{1.1025}{2.3} \\times 10^{2} $$\n$$ S \\approx 0.4793478 \\times 10^{2} $$\n$$ S \\approx 47.93478 $$\nRounding this value to three significant figures, as instructed:\n$$ S \\approx 47.9 $$\nA value of $S > 1$ indicates a supersaturated solution, where precipitation of $\\text{CaC}_{2}\\text{O}_{4}(s)$ is thermodynamically favored. The calculated value $S \\approx 47.9$ indicates a very high degree of supersaturation, consistent with the clinical presentation of urolithiasis.\n\nThe requested quantities are the Ion Activity Product (IAP) and the saturation ratio ($S$).",
            "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n1.10 \\times 10^{-7} & 47.9\n\\end{pmatrix}\n}\n$$"
        },
        {
            "introduction": "Beyond the absolute concentration of solutes, the chemical environment of the urine plays a critical role in stone formation, with pH being a primary factor for certain stone types. This exercise explores the classic example of uric acid urolithiasis, whose risk is exquisitely sensitive to urine acidity. By applying the principles of acid-base chemistry, you will calculate how changes in urine $pH$ alter the balance between soluble urate and insoluble uric acid, thereby quantifying the profound impact of $pH$ on precipitation risk .",
            "id": "4464498",
            "problem": "Uric acid urolithiasis is driven by the proportion of uric acid present in urine as the undissociated, poorly soluble weak acid form, denoted $HA$ (uric acid), as opposed to the dissociated, more soluble urate anion, denoted $A^-$. Consider uric acid in urine at body temperature $37\\,^{\\circ}\\mathrm{C}$, where the first acid dissociation constant has $pK_a = 5.35$. Assume that over the urinary $pH$ range of interest, uric acid behaves effectively as a monoprotic weak acid with the equilibrium $HA \\rightleftharpoons H^+ + A^-$. The relative risk of precipitation is proportional to the fraction of uric acid present as the undissociated form $HA$. Starting from the acid dissociation equilibrium and the definition of the acid dissociation constant, derive an expression for the fraction of $HA$ as a function of $pH$ and $pK_a$, and then compute the fold-change ratio $R$ of the undissociated fraction at $pH = 5.2$ compared to $pH = 6.0$. Report only the final fold-change ratio $R$ as a single number, rounded to three significant figures, with no units.",
            "solution": "The user wants me to solve the following problem:\n\"Uric acid urolithiasis is driven by the proportion of uric acid present in urine as the undissociated, poorly soluble weak acid form, denoted $HA$ (uric acid), as opposed to the dissociated, more soluble urate anion, denoted $A^-$. Consider uric acid in urine at body temperature $37\\,^{\\circ}\\mathrm{C}$, where the first acid dissociation constant has $pK_a = 5.35$. Assume that over the urinary $pH$ range of interest, uric acid behaves effectively as a monoprotic weak acid with the equilibrium $HA \\rightleftharpoons H^+ + A^-$. The relative risk of precipitation is proportional to the fraction of uric acid present as the undissociated form $HA$. Starting from the acid dissociation equilibrium and the definition of the acid dissociation constant, derive an expression for the fraction of $HA$ as a function of $pH$ and $pK_a$, and then compute the fold-change ratio $R$ of the undissociated fraction at $pH = 5.2$ compared to $pH = 6.0$. Report only the final fold-change ratio $R$ as a single number, rounded to three significant figures, with no units.\"\n\n### Step 1: Extract Givens\n- System: Uric acid in urine at body temperature $T = 37\\,^{\\circ}\\mathrm{C}$.\n- Uric acid is treated as a monoprotic weak acid, $HA$.\n- The conjugate base is the urate anion, $A^-$.\n- The acid dissociation equilibrium is $HA \\rightleftharpoons H^+ + A^-$.\n- The acid dissociation constant is given as $pK_a = 5.35$.\n- The relative risk of precipitation is proportional to the fraction of $HA$.\n- The first $pH$ value of interest is $pH_1 = 5.2$.\n- The second $pH$ value of interest is $pH_2 = 6.0$.\n- The task is to derive the fraction of $HA$ and compute the fold-change ratio $R$, defined as the fraction at $pH_1$ divided by the fraction at $pH_2$.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, as it is based on the well-established principles of acid-base chemistry, specifically the Henderson-Hasselbalch relationship, applied to the real-world biochemical problem of uric acid solubility and kidney stone formation. The given $pK_a$ value of $5.35$ for uric acid at body temperature is factually correct and widely accepted. The problem is well-posed, providing all necessary data ($pK_a$, $pH_1$, $pH_2$) to derive a unique expression and calculate a single, stable numerical answer. The language is objective and precise, using standard chemical terminology. The problem does not violate any of the invalidity criteria.\n\n### Step 3: Verdict and Action\nThe problem is valid. A complete solution will be provided.\n\nThe first step is to derive an expression for the fraction of uric acid present in its undissociated form, $HA$. Let this fraction be denoted by $\\alpha_{HA}$. The total concentration of uric acid species in solution, $[Total]$, is the sum of the concentrations of the undissociated acid $[HA]$ and the dissociated urate anion $[A^-]$.\n$$ [Total] = [HA] + [A^-] $$\nThe fraction $\\alpha_{HA}$ is defined as the ratio of the concentration of the undissociated acid to the total concentration:\n$$ \\alpha_{HA} = \\frac{[HA]}{[Total]} = \\frac{[HA]}{[HA] + [A^-]} $$\nTo express this fraction as a function of $pH$ and $pK_a$, we use the definition of the acid dissociation constant, $K_a$, for the equilibrium $HA \\rightleftharpoons H^+ + A^-$:\n$$ K_a = \\frac{[H^+][A^-]}{[HA]} $$\nFrom this expression, we can solve for the concentration of the urate anion, $[A^-]$:\n$$ [A^-] = K_a \\frac{[HA]}{[H^+]} $$\nNow, substitute this expression for $[A^-]$ into the denominator of the equation for $\\alpha_{HA}$:\n$$ \\alpha_{HA} = \\frac{[HA]}{[HA] + K_a \\frac{[HA]}{[H^+]}} $$\nWe can factor out $[HA]$ from the denominator, which then cancels with the numerator:\n$$ \\alpha_{HA} = \\frac{[HA]}{[HA]\\left(1 + \\frac{K_a}{[H^+]} \\right)} = \\frac{1}{1 + \\frac{K_a}{[H^+]}} $$\nThis expression relates the fraction $\\alpha_{HA}$ to $[H^+]$ and $K_a$. To express it in terms of $pH$ and $pK_a$, we use the definitions $pH = -\\log_{10}([H^+])$ and $pK_a = -\\log_{10}(K_a)$. An elegant way to do this is to use the Henderson-Hasselbalch equation, which is derived from the $K_a$ expression:\n$$ pH = pK_a + \\log_{10}\\left(\\frac{[A^-]}{[HA]}\\right) $$\nRearranging this equation gives the ratio of the concentrations of the base to the acid:\n$$ pH - pK_a = \\log_{10}\\left(\\frac{[A^-]}{[HA]}\\right) \\implies \\frac{[A^-]}{[HA]} = 10^{pH - pK_a} $$\nReturning to the definition of $\\alpha_{HA}$, we can divide both the numerator and the denominator by $[HA]$:\n$$ \\alpha_{HA} = \\frac{\\frac{[HA]}{[HA]}}{\\frac{[HA]}{[HA]} + \\frac{[A^-]}{[HA]}} = \\frac{1}{1 + \\frac{[A^-]}{[HA]}} $$\nSubstituting the expression for the ratio $\\frac{[A^-]}{[HA]}$ derived from the Henderson-Hasselbalch equation gives the final desired expression for the fraction of undissociated acid:\n$$ \\alpha_{HA}(pH, pK_a) = \\frac{1}{1 + 10^{pH - pK_a}} $$\nThis expression gives the fraction of the undissociated acid $HA$ as a function of $pH$ and $pK_a$.\n\nThe second part of the problem is to compute the fold-change ratio, $R$, of this fraction at $pH_1 = 5.2$ compared to $pH_2 = 6.0$, given $pK_a = 5.35$. The ratio $R$ is defined as:\n$$ R = \\frac{\\alpha_{HA}(pH_1, pK_a)}{\\alpha_{HA}(pH_2, pK_a)} $$\nLet's calculate the two fractions.\nThe fraction at $pH_1 = 5.2$ is:\n$$ \\alpha_{HA,1} = \\frac{1}{1 + 10^{5.2 - 5.35}} = \\frac{1}{1 + 10^{-0.15}} $$\nThe fraction at $pH_2 = 6.0$ is:\n$$ \\alpha_{HA,2} = \\frac{1}{1 + 10^{6.0 - 5.35}} = \\frac{1}{1 + 10^{0.65}} $$\nNow, we compute the ratio $R$:\n$$ R = \\frac{\\alpha_{HA,1}}{\\alpha_{HA,2}} = \\frac{\\frac{1}{1 + 10^{-0.15}}}{\\frac{1}{1 + 10^{0.65}}} = \\frac{1 + 10^{0.65}}{1 + 10^{-0.15}} $$\nTo find the numerical value, we calculate the powers of $10$:\n$$ 10^{0.65} \\approx 4.4668359 $$\n$$ 10^{-0.15} \\approx 0.7079458 $$\nSubstituting these values into the expression for $R$:\n$$ R \\approx \\frac{1 + 4.4668359}{1 + 0.7079458} = \\frac{5.4668359}{1.7079458} \\approx 3.200833 $$\nThe problem requires the answer to be rounded to three significant figures.\n$$ R \\approx 3.20 $$\nThis means that the relative amount of poorly soluble, undissociated uric acid is approximately $3.20$ times higher at $pH = 5.2$ than at $pH = 6.0$, highlighting the critical role of urinary $pH$ in the risk of uric acid stone formation.",
            "answer": "$$ \\boxed{3.20} $$"
        },
        {
            "introduction": "Having established how to calculate supersaturation and how it is influenced by urine chemistry, we can now model the effect of clinical interventions. One of the most effective and universal strategies for preventing kidney stones is increasing fluid intake to promote diuresis. This practice demonstrates quantitatively how increasing urine volume dilutes stone-forming ions, directly and powerfully reducing the supersaturation for both calcium oxalate and calcium phosphate stones, reinforcing the mechanistic basis for this cornerstone of preventive therapy .",
            "id": "4464532",
            "problem": "A patient with recurrent calcium oxalate (CaOx) and calcium phosphate (CaP) nephrolithiasis has experienced episodic urinary tract obstruction leading to hydronephrosis. To lower the risk of new stone formation, the clinician advises increasing daily urine volume from $V_{1} = 1.0\\ \\mathrm{L/day}$ to $V_{2} = 2.5\\ \\mathrm{L/day}$ without changing diet or pharmacotherapy. Assume daily renal excretion rates remain fixed at $E_{\\mathrm{Ca}} = 200\\ \\mathrm{mg/day}$ for calcium, $E_{\\mathrm{Ox}} = 40\\ \\mathrm{mg/day}$ for oxalate, and $E_{\\mathrm{P}} = 900\\ \\mathrm{mg/day}$ for total inorganic phosphate. Let the molar masses be $M_{\\mathrm{Ca}} = 40.08\\ \\mathrm{g/mol}$, $M_{\\mathrm{Ox}} = 88.02\\ \\mathrm{g/mol}$ for oxalate $\\text{C}_{2}\\text{O}_{4}^{2-}$, and $M_{\\mathrm{P}} = 94.97\\ \\mathrm{g/mol}$ for phosphate $\\text{PO}_{4}^{3-}$. Urine potential of hydrogen (pH) is fixed at $pH = 6.0$. Treat activity coefficients as $1$ and neglect complexation and ionic strength effects. For calcium phosphate, assume brushite-like nucleation where the relevant anion is $\\text{HPO}_{4}^{2-}$. The fraction of total phosphate as $\\text{HPO}_{4}^{2-}$ at fixed $pH$ is governed by the Hendersonâ€“Hasselbalch relation for the acid dissociation constant ($K_{a}$) of $\\text{H}_{2}\\text{PO}_{4}^{-} \\leftrightarrow \\text{HPO}_{4}^{2-} + \\text{H}^{+}$, with $pK_{a2} = 7.21$ and $pK_{a2} = -\\log_{10}(K_{a2})$.\n\nSupersaturation ($S$) is defined by the ion activity product (IAP) and the solubility product constant ($K_{sp}$) via $S = \\mathrm{IAP}/K_{sp}$. For CaOx, take $\\text{IAP}_{\\text{CaOx}} \\approx [\\text{Ca}^{2+}][\\text{C}_{2}\\text{O}_{4}^{2-}]$. For CaP (brushite-like), take $\\text{IAP}_{\\text{CaP}} \\approx [\\text{Ca}^{2+}][\\text{HPO}_{4}^{2-}]$.\n\nUsing these foundations and the assumption that excretion rates are unchanged while urine volume increases from $V_{1}$ to $V_{2}$, derive the multiplicative change in supersaturation for CaOx and CaP, i.e., compute the dimensionless ratios $S_{\\mathrm{CaOx},2}/S_{\\mathrm{CaOx},1}$ and $S_{\\mathrm{CaP},2}/S_{\\mathrm{CaP},1}$. Express your final answer as a row matrix containing the two ratios in the order $\\left(S_{\\mathrm{CaOx},2}/S_{\\mathrm{CaOx},1}\\ \\ S_{\\mathrm{CaP},2}/S_{\\mathrm{CaP},1}\\right)$. Round your answers to four significant figures and report them as dimensionless numbers without units.",
            "solution": "The user wants me to validate the provided problem and, if valid, provide a reasoned solution.\n\n### Step 1: Extract Givens\n- Initial urine volume: $V_{1} = 1.0\\ \\mathrm{L/day}$\n- Final urine volume: $V_{2} = 2.5\\ \\mathrm{L/day}$\n- Daily calcium excretion rate: $E_{\\mathrm{Ca}} = 200\\ \\mathrm{mg/day}$\n- Daily oxalate excretion rate: $E_{\\mathrm{Ox}} = 40\\ \\mathrm{mg/day}$\n- Daily total inorganic phosphate excretion rate: $E_{\\mathrm{P}} = 900\\ \\mathrm{mg/day}$\n- Molar mass of Calcium: $M_{\\mathrm{Ca}} = 40.08\\ \\mathrm{g/mol}$\n- Molar mass of Oxalate ($\\text{C}_{2}\\text{O}_{4}^{2-}$): $M_{\\mathrm{Ox}} = 88.02\\ \\mathrm{g/mol}$\n- Molar mass of Phosphate ($\\text{PO}_{4}^{3-}$): $M_{\\mathrm{P}} = 94.97\\ \\mathrm{g/mol}$\n- Urine potential of hydrogen: $pH = 6.0$ (fixed)\n- Assumption: Activity coefficients are $1$.\n- Assumption: Neglect complexation and ionic strength effects.\n- Relevant anion for Calcium Phosphate (CaP): $\\text{HPO}_{4}^{2-}$\n- Acid dissociation constant for $\\text{H}_{2}\\text{PO}_{4}^{-} \\leftrightarrow \\text{HPO}_{4}^{2-} + \\text{H}^{+}$: $pK_{a2} = 7.21$\n- Definition of supersaturation ($S$): $S = \\mathrm{IAP}/K_{sp}$, where $\\mathrm{IAP}$ is the ion activity product and $K_{sp}$ is the solubility product constant.\n- Ion Activity Product for Calcium Oxalate (CaOx): $\\text{IAP}_{\\text{CaOx}} \\approx [\\text{Ca}^{2+}][\\text{C}_{2}\\text{O}_{4}^{2-}]$\n- Ion Activity Product for Calcium Phosphate (CaP): $\\text{IAP}_{\\text{CaP}} \\approx [\\text{Ca}^{2+}][\\text{HPO}_{4}^{2-}]$\n- Goal: Compute the ratios $S_{\\mathrm{CaOx},2}/S_{\\mathrm{CaOx},1}$ and $S_{\\mathrm{CaP},2}/S_{\\mathrm{CaP},1}$.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded**: The problem is based on fundamental principles of solution chemistry (concentration, solubility, acid-base equilibrium) applied to the relevant medical topic of urolithiasis. The given physiological parameters and chemical constants are realistic. The simplifications (e.g., unit activity coefficients) are explicitly stated and appropriate for a first-order analysis. The problem is scientifically sound.\n- **Well-Posed**: The problem provides all necessary information to determine the change in supersaturation. A unique and meaningful solution exists.\n- **Objective**: The problem is stated in precise, quantitative, and unbiased language.\n- **Verdict**: The problem does not violate any of the invalidity criteria. It is a valid, well-posed scientific problem.\n\n### Step 3: Verdict and Action\nThe problem is valid. A detailed solution will be provided.\n\nThe objective is to compute the multiplicative change in supersaturation for calcium oxalate ($S_{\\mathrm{CaOx}}$) and calcium phosphate ($S_{\\mathrm{CaP}}$) when the daily urine volume is increased from $V_{1}$ to $V_{2}$, while daily excretion rates of solutes remain constant. Let the subscript $i$ denote the state, where $i=1$ corresponds to volume $V_{1}$ and $i=2$ corresponds to volume $V_{2}$.\n\nThe molar concentration $[X]_{i}$ of any solute $X$ in the urine at state $i$ is the ratio of its molar excretion rate, $\\dot{n}_X$ (in $\\mathrm{mol/day}$), to the urine volume, $V_{i}$ (in $\\mathrm{L/day}$). The molar excretion rate is obtained from the mass excretion rate, $E_X$ (in $\\mathrm{mg/day}$), and the molar mass, $M_X$ (in $\\mathrm{g/mol}$), as follows:\n$$\n[X]_{i} = \\frac{\\dot{n}_X}{V_i} = \\frac{E_X \\times 10^{-3} \\mathrm{g/day}}{M_X \\mathrm{g/mol} \\cdot V_i \\mathrm{L/day}} = \\frac{E_X \\times 10^{-3}}{M_X V_i} \\ \\mathrm{mol/L}\n$$\nSince $E_X$ and $M_X$ are constants for a given solute, the concentration is inversely proportional to the urine volume: $[X]_{i} \\propto \\frac{1}{V_i}$.\n\n**1. Calcium Oxalate ($CaOx$) Supersaturation Ratio**\n\nThe supersaturation of calcium oxalate is defined as $S_{\\mathrm{CaOx},i} = \\mathrm{IAP}_{\\mathrm{CaOx},i} / K_{sp,\\mathrm{CaOx}}$. The ion activity product is given by $\\text{IAP}_{\\text{CaOx},i} \\approx [\\text{Ca}^{2+}]_{i}[\\text{C}_{2}\\text{O}_{4}^{2-}]_{i}$.\nThe concentrations of calcium and oxalate ions at state $i$ are:\n$$\n[\\mathrm{Ca}^{2+}]_{i} = \\frac{E_{\\mathrm{Ca}} \\times 10^{-3}}{M_{\\mathrm{Ca}} V_{i}}\n$$\n$$\n[\\mathrm{C}_{2}\\mathrm{O}_{4}^{2-}]_{i} = \\frac{E_{\\mathrm{Ox}} \\times 10^{-3}}{M_{\\mathrm{Ox}} V_{i}}\n$$\nThus, the ion activity product for CaOx at state $i$ is:\n$$\n\\mathrm{IAP}_{\\mathrm{CaOx},i} = \\left(\\frac{E_{\\mathrm{Ca}} \\times 10^{-3}}{M_{\\mathrm{Ca}} V_{i}}\\right) \\left(\\frac{E_{\\mathrm{Ox}} \\times 10^{-3}}{M_{\\mathrm{Ox}} V_{i}}\\right) = \\frac{(E_{\\mathrm{Ca}} \\times 10^{-3})(E_{\\mathrm{Ox}} \\times 10^{-3})}{M_{\\mathrm{Ca}} M_{\\mathrm{Ox}}} \\frac{1}{V_i^2}\n$$\nThe supersaturation is then:\n$$\nS_{\\mathrm{CaOx},i} = \\frac{1}{K_{sp,\\mathrm{CaOx}}} \\left( \\frac{(E_{\\mathrm{Ca}} \\times 10^{-3})(E_{\\mathrm{Ox}} \\times 10^{-3})}{M_{\\mathrm{Ca}} M_{\\mathrm{Ox}}} \\right) \\frac{1}{V_i^2}\n$$\nTo find the multiplicative change, we compute the ratio $S_{\\mathrm{CaOx},2} / S_{\\mathrm{CaOx},1}$. All terms are constant except for $V_i$.\n$$\n\\frac{S_{\\mathrm{CaOx},2}}{S_{\\mathrm{CaOx},1}} = \\frac{\\frac{1}{K_{sp,\\mathrm{CaOx}}} \\left( \\frac{\\cdots}{\\cdots} \\right) \\frac{1}{V_2^2}}{\\frac{1}{K_{sp,\\mathrm{CaOx}}} \\left( \\frac{\\cdots}{\\cdots} \\right) \\frac{1}{V_1^2}} = \\frac{1/V_2^2}{1/V_1^2} = \\left(\\frac{V_1}{V_2}\\right)^2\n$$\n\n**2. Calcium Phosphate ($CaP$) Supersaturation Ratio**\n\nThe supersaturation of calcium phosphate (as brushite) is defined as $S_{\\mathrm{CaP},i} = \\mathrm{IAP}_{\\mathrm{CaP},i} / K_{sp,\\mathrm{CaP}}$. The ion activity product is $\\text{IAP}_{\\text{CaP},i} \\approx [\\text{Ca}^{2+}]_{i}[\\text{HPO}_{4}^{2-}]_{i}$.\n\nThe calcium concentration, $[\\mathrm{Ca}^{2+}]_{i}$, is the same as before and is proportional to $1/V_i$. We must now determine the concentration of the dibasic phosphate ion, $[\\mathrm{HPO}_{4}^{2-}]_{i}$.\nThe total molar concentration of all phosphate species, $[\\mathrm{P}]_{\\mathrm{total},i}$, is given by:\n$$\n[\\mathrm{P}]_{\\mathrm{total},i} = \\frac{E_{\\mathrm{P}} \\times 10^{-3}}{M_{\\mathrm{P}} V_i}\n$$\nThis total phosphate is distributed among different protonated species ($\\mathrm{H}_{3}\\mathrm{PO}_{4}$, $\\mathrm{H}_{2}\\mathrm{PO}_{4}^{-}$, $\\mathrm{HPO}_{4}^{2-}$, $\\mathrm{PO}_{4}^{3-}$). The fraction of total phosphate present as $\\mathrm{HPO}_{4}^{2-}$ is denoted $\\alpha_{\\mathrm{HPO}_{4}^{2-}}$.\n$$\n[\\mathrm{HPO}_{4}^{2-}]_{i} = \\alpha_{\\mathrm{HPO}_{4}^{2-}} [\\mathrm{P}]_{\\mathrm{total},i}\n$$\nThis fraction $\\alpha_{\\mathrm{HPO}_{4}^{2-}}$ is determined by the urine $pH$ and the acid dissociation constants of phosphoric acid. The problem specifies the relevant equilibrium is $\\mathrm{H}_{2}\\mathrm{PO}_{4}^{-} \\leftrightarrow \\mathrm{HPO}_{4}^{2-} + \\mathrm{H}^{+}$ with $pK_{a2} = 7.21$. At the given $pH=6.0$, the dominant species are $\\mathrm{H}_{2}\\mathrm{PO}_{4}^{-}$ and $\\mathrm{HPO}_{4}^{2-}$, so we can approximate $[\\mathrm{P}]_{\\mathrm{total}} \\approx [\\mathrm{H}_{2}\\mathrm{PO}_{4}^{-}] + [\\mathrm{HPO}_{4}^{2-}]$. The Henderson-Hasselbalch equation relates their ratio:\n$$\npH = pK_{a2} + \\log_{10}\\left(\\frac{[\\mathrm{HPO}_{4}^{2-}]}{[\\mathrm{H}_{2}\\mathrm{PO}_{4}^{-}]}\\right)\n$$\nThe ratio $R = [\\mathrm{HPO}_{4}^{2-}]/[\\mathrm{H}_{2}\\mathrm{PO}_{4}^{-}]$ is therefore $R = 10^{pH - pK_{a2}}$. The fraction $\\alpha_{\\mathrm{HPO}_{4}^{2-}}$ is given by:\n$$\n\\alpha_{\\mathrm{HPO}_{4}^{2-}} = \\frac{[\\mathrm{HPO}_{4}^{2-}]}{[\\mathrm{H}_{2}\\mathrm{PO}_{4}^{-}] + [\\mathrm{HPO}_{4}^{2-}]} = \\frac{R[\\mathrm{H}_{2}\\mathrm{PO}_{4}^{-}]}{[\\mathrm{H}_{2}\\mathrm{PO}_{4}^{-}] + R[\\mathrm{H}_{2}\\mathrm{PO}_{4}^{-}]} = \\frac{R}{1+R} = \\frac{10^{pH - pK_{a2}}}{1+10^{pH - pK_{a2}}}\n$$\nSince both $pH$ and $pK_{a2}$ are constant in this problem, the fraction $\\alpha_{\\mathrm{HPO}_{4}^{2-}}$ is also a constant, independent of urine volume $V_i$.\nTherefore, the concentration of the dibasic phosphate ion is:\n$$\n[\\mathrm{HPO}_{4}^{2-}]_{i} = \\alpha_{\\mathrm{HPO}_{4}^{2-}} [\\mathrm{P}]_{\\mathrm{total},i} = \\alpha_{\\mathrm{HPO}_{4}^{2-}} \\left(\\frac{E_{\\mathrm{P}} \\times 10^{-3}}{M_{\\mathrm{P}} V_i}\\right)\n$$\nLike all other solutes, $[\\mathrm{HPO}_{4}^{2-}]_{i} \\propto 1/V_i$.\nThe ion activity product for CaP at state $i$ is:\n$$\n\\mathrm{IAP}_{\\mathrm{CaP},i} = [\\mathrm{Ca}^{2+}]_{i}[\\mathrm{HPO}_{4}^{2-}]_{i} = \\left(\\frac{E_{\\mathrm{Ca}} \\times 10^{-3}}{M_{\\mathrm{Ca}} V_{i}}\\right) \\left(\\alpha_{\\mathrm{HPO}_{4}^{2-}} \\frac{E_{\\mathrm{P}} \\times 10^{-3}}{M_{\\mathrm{P}} V_i}\\right) = \\frac{\\alpha_{\\mathrm{HPO}_{4}^{2-}}(E_{\\mathrm{Ca}} \\times 10^{-3})(E_{\\mathrm{P}} \\times 10^{-3})}{M_{\\mathrm{Ca}} M_{\\mathrm{P}}} \\frac{1}{V_i^2}\n$$\nThe supersaturation is $S_{\\mathrm{CaP},i} = \\mathrm{IAP}_{\\mathrm{CaP},i} / K_{sp,\\mathrm{CaP}}$. We form the ratio $S_{\\mathrm{CaP},2} / S_{\\mathrm{CaP},1}$:\n$$\n\\frac{S_{\\mathrm{CaP},2}}{S_{\\mathrm{CaP},1}} = \\frac{\\frac{1}{K_{sp,\\mathrm{CaP}}} \\left( \\frac{\\cdots}{\\cdots} \\right) \\frac{1}{V_2^2}}{\\frac{1}{K_{sp,\\mathrm{CaP}}} \\left( \\frac{\\cdots}{\\cdots} \\right) \\frac{1}{V_1^2}} = \\frac{1/V_2^2}{1/V_1^2} = \\left(\\frac{V_1}{V_2}\\right)^2\n$$\nBoth ratios simplify to the same expression.\n\n**3. Numerical Calculation**\n\nGiven $V_{1} = 1.0\\ \\mathrm{L/day}$ and $V_{2} = 2.5\\ \\mathrm{L/day}$, the ratio is:\n$$\n\\left(\\frac{V_1}{V_2}\\right)^2 = \\left(\\frac{1.0}{2.5}\\right)^2 = (0.4)^2 = 0.16\n$$\nRounding to four significant figures, the result is $0.1600$. This value is the same for both $S_{\\mathrm{CaOx},2}/S_{\\mathrm{CaOx},1}$ and $S_{\\mathrm{CaP},2}/S_{\\mathrm{CaP},1}$. The final answer should be presented as a row matrix.",
            "answer": "$$ \\boxed{ \\begin{pmatrix} 0.1600 & 0.1600 \\end{pmatrix} } $$"
        }
    ]
}